Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 10 | 6061799 | intron variant | C/A;T | snv |
|
0.700 | 1.000 | 1 | 2014 | 2014 | ||||||||||
|
0.851 | 0.200 | 10 | 6055320 | intron variant | T/C | snv | 7.0E-02 |
|
Eye Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.662 | 0.440 | 10 | 6057082 | intron variant | T/C | snv | 0.18 |
|
Eye Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.662 | 0.440 | 10 | 6057082 | intron variant | T/C | snv | 0.18 |
|
Immune System Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.752 | 0.360 | 10 | 6059750 | intron variant | T/A;C | snv |
|
Immune System Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.925 | 0.120 | 10 | 6054236 | intron variant | G/T | snv | 0.45 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.925 | 0.120 | 10 | 6045831 | intron variant | G/A | snv | 0.28 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.776 | 0.240 | 10 | 6053447 | intron variant | A/T | snv | 0.25 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.925 | 0.120 | 10 | 6046736 | intron variant | A/G | snv | 0.51 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.882 | 0.080 | 10 | 6051176 | intron variant | C/T | snv | 7.8E-03 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
1.000 | 10 | 6061799 | intron variant | C/A;T | snv |
|
0.700 | 1.000 | 1 | 2014 | 2014 | ||||||||||
|
0.776 | 0.280 | 10 | 6052734 | intron variant | C/T | snv | 5.7E-02 |
|
Immune System Diseases | 0.700 | 1.000 | 2 | 2017 | 2018 | |||||||
|
10 | 6032488 | intron variant | G/A;C;T | snv |
|
Immune System Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||||
|
0.752 | 0.360 | 10 | 6059750 | intron variant | T/A;C | snv |
|
Skin and Connective Tissue Diseases | 0.800 | 1.000 | 2 | 2010 | 2015 | ||||||||
|
0.662 | 0.440 | 10 | 6057082 | intron variant | T/C | snv | 0.18 |
|
Musculoskeletal Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.827 | 0.120 | 10 | 6060794 | intron variant | A/G | snv | 0.24 |
|
Musculoskeletal Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.776 | 0.280 | 10 | 6052734 | intron variant | C/T | snv | 5.7E-02 |
|
Musculoskeletal Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.695 | 0.320 | 10 | 6056986 | intron variant | C/T | snv | 0.46 |
|
Musculoskeletal Diseases | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.882 | 0.080 | 10 | 6051176 | intron variant | C/T | snv | 7.8E-03 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 2 | 2019 | 2019 | |||||||
|
0.776 | 0.280 | 10 | 6052734 | intron variant | C/T | snv | 5.7E-02 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.080 | 10 | 6013641 | intron variant | C/A;T | snv |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.851 | 0.200 | 10 | 6055320 | intron variant | T/C | snv | 7.0E-02 |
|
0.700 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
0.695 | 0.320 | 10 | 6056986 | intron variant | C/T | snv | 0.46 |
|
0.700 | 1.000 | 2 | 2015 | 2019 | ||||||||
|
0.695 | 0.320 | 10 | 6056986 | intron variant | C/T | snv | 0.46 |
|
0.700 | 1.000 | 2 | 2015 | 2019 | ||||||||
|
0.695 | 0.320 | 10 | 6056986 | intron variant | C/T | snv | 0.46 |
|
0.700 | 1.000 | 2 | 2015 | 2019 |